Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Kidney Transplantation

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 123 articles:
HTML format



Single Articles


    June 2022
  1. VAN DER WEIJDEN J, Mahesh SVK, van Londen M, Bakker SJL, et al
    Early increase in single-kidney glomerular filtration rate after living kidney donation predicts long-term kidney function.
    Kidney Int. 2022;101:1251-1259.
    PubMed     Abstract available


    May 2022
  2. BERTRAND D, Laurent C, Lemee V, Lebourg L, et al
    Efficacy of anti SARS-CoV-2 monoclonal antibodies prophylaxis and vaccination on Omicron COVID-19 in kidney transplant recipients.
    Kidney Int. 2022 May 23. pii: S0085-2538(22)00382.
    PubMed    


  3. BASU S, Dorling A
    Regulation of T- and B-cell interactions determines the clinical phenotype associated with donor-specific antibodies.
    Kidney Int. 2022;101:877-879.
    PubMed     Abstract available


    April 2022
  4. BURTON H, McLaughlin L, Shiu KY, Shaw O, et al
    The phenotype of HLA-binding B-cells from sensitized kidney transplant recipients correlates with clinically prognostic patterns of interferon-gamma production against purified HLA proteins.
    Kidney Int. 2022 Apr 25. pii: S0085-2538(22)00339.
    PubMed     Abstract available


  5. AL JURDI A, Gassen RB, Borges TJ, Lape IT, et al
    Suboptimal antibody response against SARS-CoV-2 Omicron variant after third dose of mRNA vaccine in kidney transplant recipients.
    Kidney Int. 2022 Apr 13. pii: S0085-2538(22)00288.
    PubMed    


  6. CHAVAROT N, Melenotte C, Amrouche L, Rouzaud C, et al
    Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection.
    Kidney Int. 2022 Apr 11. pii: S0085-2538(22)00272.
    PubMed    


  7. HUANG E, Jordan SC
    Donor-derived cell-free DNA in kidney transplantation: evolving concepts and potential limitations.
    Kidney Int. 2022;101:676-677.
    PubMed     Abstract available


  8. LASSEN E, Daehn IS
    Hypertrophy and glomerular cell adaptation through crosstalk leads to glomerular injury after kidney transplantation.
    Kidney Int. 2022;101:673-676.
    PubMed     Abstract available


  9. LOGEL SN, Connor EL, Paloian NJ
    The Case | A 17-year-old boy with growth failure and chronic kidney disease.
    Kidney Int. 2022;101:837-838.
    PubMed    


    March 2022
  10. PERKINS GB, Tunbridge M, Salehi T, Chai CS, et al
    Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19.
    Kidney Int. 2022 Mar 15. pii: S0085-2538(22)00172.
    PubMed    


  11. SUWELACK B, Berger K, Wolters H, Gerss JWO, et al
    Results of the prospective multicenter SoLKiD cohort study indicate bio-psycho-social outcome risks to kidney donors 12 months after donation.
    Kidney Int. 2022;101:597-606.
    PubMed     Abstract available


    February 2022
  12. BENOTMANE I, Bruel T, Planas D, Fafi-Kremer S, et al
    A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the delta variant in kidney transplant recipients.
    Kidney Int. 2022 Feb 26. pii: S0085-2538(22)00168.
    PubMed    


  13. MASSET C, Benotmane I, Dantal J, Garandeau C, et al
    A fourth SARS-Cov-2 mRNA vaccine in strictly seronegative kidney transplant recipients.
    Kidney Int. 2022 Feb 12. pii: S0085-2538(22)00093.
    PubMed    


  14. ERPICUM P, Grosch S, Bonvoisin C, Bouquegneau A, et al
    The Case | An unusual cause of renal vascular thrombi after kidney transplantation.
    Kidney Int. 2022;101:427-428.
    PubMed    


    January 2022
  15. LOUIS K, Fadakar P, Macedo C, Yamada M, et al
    Concomitant loss of regulatory T and B cells is a distinguishing immune feature of antibody-mediated rejection in kidney transplantation.
    Kidney Int. 2022 Jan 25. pii: S0085-2538(22)00027.
    PubMed     Abstract available


  16. DUCLOUX D, Courivaud C
    REGEN-Cov antibody combination to prevent COVID-19 infection in kidney transplant recipient without detectable antibody response to optimal vaccine scheme.
    Kidney Int. 2022 Jan 4. pii: S0085-2538(21)01216.
    PubMed    


  17. JEFFERIS J, Kassianos AJ, Grivei A, Doucet B, et al
    SARS-CoV-2 vaccination-associated collapsing glomerulopathy in a kidney transplant recipient.
    Kidney Int. 2022 Jan 4. pii: S0085-2538(21)01219.
    PubMed    


  18. SALEM F, Perin L, Sedrakyan S, Angeletti A, et al
    The spatially resolved transcriptional profile of acute T cell-mediated rejection in a kidney allograft.
    Kidney Int. 2022;101:131-136.
    PubMed     Abstract available


    December 2021
  19. BENNING L, Morath C, Bartenschlager M, Reineke M, et al
    Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared to two-dose BNT162b2 vaccination in kidney transplant recipients.
    Kidney Int. 2021 Dec 23. pii: S0085-2538(21)01169.
    PubMed    


  20. SUGIANTO RI, Memaran N, Schmidt BMW, Doyon A, et al
    Insights from the 4C-T Study suggest increased cardiovascular burden in girls with end stage kidney disease before and after kidney transplantation.
    Kidney Int. 2021 Dec 21. pii: S0085-2538(21)01163.
    PubMed     Abstract available


  21. MENON R, Otto EA, Berthier CC, Nair V, et al
    Glomerular endothelial cell-podocyte stresses and crosstalk in structurally normal kidney transplants.
    Kidney Int. 2021 Dec 21. pii: S0085-2538(21)01162.
    PubMed     Abstract available


  22. LOUPY A, Mengel M, Haas M
    30 years of the International Banff Classification for Allograft Pathology: The Past, Present and Future of Kidney Transplant Diagnostics.
    Kidney Int. 2021 Dec 16. pii: S0085-2538(21)01142.
    PubMed     Abstract available


  23. CALLEMEYN J, Lamarthee B, Koenig A, Koshy P, et al
    Allorecognition and the spectrum of kidney transplant rejection.
    Kidney Int. 2021 Dec 13. pii: S0085-2538(21)01143.
    PubMed     Abstract available


  24. MASSET C, Ville S, Garandeau C, Le Borgne F, et al
    Observations on improving COVID-19 vaccination responses in kidney transplant recipients: heterologous vaccination and immunosuppression modulation.
    Kidney Int. 2021 Dec 8. pii: S0085-2538(21)01136.
    PubMed    


  25. HEYBELI C, Bentall A, Wen J, Alexander MP, et al
    Corrigendum to Heybeli C, Bentall A, Wen J, et al. A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis. Kidney Int. 2021;99:707-715.
    Kidney Int. 2021;100:1348-1349.
    PubMed    


    November 2021
  26. ASHCROFT J, Leighton P, Elliott TR, Hosgood SA, et al
    Extracellular Vesicles in Kidney Transplantation: A State of the Art Review.
    Kidney Int. 2021 Nov 25. pii: S0085-2538(21)01082.
    PubMed     Abstract available


    October 2021
  27. YI Z, Salem F, Menon MC, Keung K, et al
    Deep learning identified pathological abnormalities predictive of graft loss in kidney transplant biopsies.
    Kidney Int. 2021 Oct 29. pii: S0085-2538(21)01025.
    PubMed     Abstract available


  28. BERTRAND D, Hamzaoui M, Lemee V, Lamulle J, et al
    Antibody and T cell response to a third dose of SARS-CoV-2 messenger RNA BNT162b2 vaccine in kidney transplant recipients.
    Kidney Int. 2021 Oct 4. pii: S0085-2538(21)00924.
    PubMed    


  29. DUCLOUX D, Courivaud C
    Should vaccination against COVID-19 be mandated in patients on the transplant waiting list?
    Kidney Int. 2021;100:939-940.
    PubMed    


  30. LEFAUCHEUR C, Louis K, Philippe A, Loupy A, et al
    The emerging field of non-human leukocyte antigen antibodies in transplant medicine and beyond.
    Kidney Int. 2021;100:787-798.
    PubMed     Abstract available


    September 2021
  31. PEDERSEN RM, Bang LL, Tornby DS, Kierkegaard H, et al
    The SARS-CoV-2-neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine.
    Kidney Int. 2021 Sep 20. pii: S0085-2538(21)00866.
    PubMed    


  32. WESTHOFF TH, Seibert FS, Anft M, Blazquez-Navarro A, et al
    A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral non-response.
    Kidney Int. 2021 Sep 9. pii: S0085-2538(21)00850.
    PubMed    


  33. AZZI Y, Raees H, Wang T, Cleare L, et al
    Risks factors associated with poor response to COVID-19 vaccination in kidney transplant recipients.
    Kidney Int. 2021 Sep 2. pii: S0085-2538(21)00826.
    PubMed    


    August 2021
  34. DE GREEF J, Devresse A, Albichr IS, Scohy A, et al
    Better Late than Never: Eventual Seroconversion against SARS-CoV-2 in a Kidney Transplant Recipient after Repeated Immune Challenge and Monoclonal Antibody Therapy.
    Kidney Int. 2021 Aug 31. pii: S0085-2538(21)00825.
    PubMed    


  35. MASSET C, Kerleau C, Garandeau C, Ville S, et al
    A third injection of BNT162b2 mRNA Covid-19 vaccine in kidney transplant recipients improves the humoral immune response.
    Kidney Int. 2021 Aug 30. pii: S0085-2538(21)00809.
    PubMed    


  36. CHAVAROT N, Parize P, Podglajen I, Sberro-Soussan R, et al
    The Case | Cardiac tamponade in a kidney transplant recipient with chronic inflammation.
    Kidney Int. 2021;100:487-488.
    PubMed    


  37. MENGEL M, Lubetzky M
    Do we need to treat chronic active T cell-mediated rejection?
    Kidney Int. 2021;100:275-277.
    PubMed     Abstract available


  38. CAILLARD S, Chavarot N, Bertrand D, Kamar N, et al
    Occurrence of severe COVID-19 in vaccinated transplant patients.
    Kidney Int. 2021;100:477-479.
    PubMed    


  39. ARYKBAEVA AS, de Vries DK, Doppenberg JB, Engelse MA, et al
    Metabolic needs of the kidney graft undergoing normothermic machine perfusion.
    Kidney Int. 2021;100:301-310.
    PubMed     Abstract available


  40. KUNG VL, Sandhu R, Haas M, Huang E, et al
    Chronic active T cell-mediated rejection is variably responsive to immunosuppressive therapy.
    Kidney Int. 2021;100:391-400.
    PubMed     Abstract available


  41. SENEV A, Van Loon E, Lerut E, Callemeyn J, et al
    Risk factors, histopathological features, and graft outcome of transplant glomerulopathy in the absence of donor-specific HLA antibodies.
    Kidney Int. 2021;100:401-414.
    PubMed     Abstract available


    July 2021
  42. TAMBUR AR, Kosmoliaptsis V, Claas FH, Mannon RB, et al
    Significance of HLA-DQ in kidney transplantation - Time to re-evaluate HLA matching priorities to improve transplant outcomes? An expert review and recommendations.
    Kidney Int. 2021 Jul 8. pii: S0085-2538(21)00657.
    PubMed     Abstract available


  43. DALOUL R, Pesavento T, Goldberg DS, Reese PP, et al
    A Review of kidney transplantation from HCV-Viremic Donors into Negative Recipients.
    Kidney Int. 2021 Jul 5. pii: S0085-2538(21)00669.
    PubMed     Abstract available


  44. MADHAVAN SM
    APOL1 genotyping in kidney transplantation: a look into the future.
    Kidney Int. 2021;100:32-34.
    PubMed    


  45. KUMAR V, Locke JE
    APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (contra).
    Kidney Int. 2021;100:30-32.
    PubMed    


  46. FREEDMAN BI, Poggio ED
    APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro).
    Kidney Int. 2021;100:27-30.
    PubMed    


  47. YAMADA M, Iwamoto H, Konno O, Kihara Y, et al
    Pelvic arteriovenous malformation in a kidney transplant recipient.
    Kidney Int. 2021;100:246.
    PubMed    


  48. BERCHTOLD L, Letouze E, Alexander MP, Canaud G, et al
    Corrigendum to Berchtold L, Letouze E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99:671-685.
    Kidney Int. 2021;100:243.
    PubMed    


    June 2021
  49. IKIZLER TA, Coates PT, Rovin BH, Ronco P, et al
    Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy.
    Kidney Int. 2021;99:1275-1279.
    PubMed     Abstract available


  50. RAMSPEK CL, El Moumni M, Wali E, Heemskerk MBA, et al
    Development and external validation study combining existing models and recent data into an up-to-date prediction model for evaluating kidneys from older deceased donors for transplantation.
    Kidney Int. 2021;99:1459-1469.
    PubMed     Abstract available


    May 2021
  51. DOLFF S, Baotong Z, Korth J, De L, et al
    Evidence of Cell Mediated Immune response in kidney transplants with negative mRNA-1273 Antibody Response.
    Kidney Int. 2021 May 21. pii: S0085-2538(21)00511.
    PubMed    


  52. THIRUNAVUKKARASU B, Nada R, Ramachandran R, Sakhuja V, et al
    Epstein-Barr virus-associated hepatic smooth muscle tumor post-renal transplant.
    Kidney Int. 2021;99:1245.
    PubMed    


  53. LIANG EN W, Tan CS, Conceicao EP, Venkatachalam I, et al
    Zero health care-associated respiratory viral infections: impact of enhanced infection prevention on a renal unit during the coronavirus disease 2019 pandemic.
    Kidney Int. 2021;99:1236-1238.
    PubMed    


  54. SOTOMAYOR CG, Groothof D, Vodegel JJ, Eisenga MF, et al
    Plasma cadmium is associated with increased risk of long-term kidney graft failure.
    Kidney Int. 2021;99:1213-1224.
    PubMed     Abstract available


  55. DUJARDIN A, Lorent M, Foucher Y, Legendre C, et al
    Time-dependent lymphocyte count after transplantation is associated with higher risk of graft failure and death.
    Kidney Int. 2021;99:1189-1201.
    PubMed     Abstract available


    April 2021
  56. CHANG CC, Vlad G, Vasilescu ER, Husain SA, et al
    Disparity between levels of anti-RBD IgG and anti-nucleocapsid protein IgG antibodies in COVID-19-recovered patients who received a kidney transplant.
    Kidney Int. 2021 Apr 30. pii: S0085-2538(21)00457.
    PubMed    


  57. PUTTARAJAPPA CM, Jorgensen D, Yabes JG, Jeong K, et al
    Trends and impact on cold ischemia time and clinical outcomes using virtual crossmatch for deceased donor kidney transplantation in the United States.
    Kidney Int. 2021 Apr 30. pii: S0085-2538(21)00460.
    PubMed     Abstract available


  58. DEL BELLO A, Marion O, Delas A, Congy-Jolivet N, et al
    Acute rejection after anti-SARS-CoV-2 mRNA vaccination in a kidney-transplant patient.
    Kidney Int. 2021 Apr 28. pii: S0085-2538(21)00466.
    PubMed    


  59. CLAUDIO P, Rosaria CM
    The inflammatory state is a risk factor for cardiovascular disease and graft fibrosis in kidney transplantation.
    Kidney Int. 2021 Apr 28. pii: S0085-2538(21)00454.
    PubMed     Abstract available


  60. BENOTMANE I, Gautier-Vargas G, Cognard N, Olagne J, et al
    Low immunization rates among kidney transplant recipients who received two doses of the mRNA-1273 SARS-CoV-2 vaccine.
    Kidney Int. 2021 Apr 19. pii: S0085-2538(21)00389.
    PubMed    


  61. COOREY CP, Sharma A, Muller S, Yang JYH, et al
    Prediction modeling-part 2: using machine learning strategies to improve transplantation outcomes.
    Kidney Int. 2021;99:817-823.
    PubMed     Abstract available


    March 2021
  62. BENOTMANE I, Gautier-Vargas G, Cognard N, Olagne J, et al
    Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.
    Kidney Int. 2021 Mar 25. pii: S0085-2538(21)00348.
    PubMed    


  63. NIMMO A, Ravanan R, Taylor DM
    The authors reply.
    Kidney Int. 2021;99:772-773.
    PubMed    


  64. DUCLOUX D, Rebibou JM, Courivaud C
    Pretransplant coronary artery disease screening is still valid.
    Kidney Int. 2021;99:772.
    PubMed    


  65. ROBSON KJ, Kitching AR
    Recurrent membranous nephropathy after transplantation: donor antigen and HLA converge in defining risk.
    Kidney Int. 2021;99:545-548.
    PubMed     Abstract available


    February 2021
  66. KOO TY, Lee JH, Min SI, Lee Y, et al
    Presence of a survival benefit of HLA-incompatible living donor kidney transplantation compared to waiting or HLA-compatible deceased donor kidney transplantation with a long waiting time.
    Kidney Int. 2021 Feb 26. pii: S0085-2538(21)00258.
    PubMed     Abstract available


  67. CHAVAROT N, Leruez-Ville M, Scemla A, Burger C, et al
    Decline and loss of anti-SARS-CoV-2 antibodies in kidney transplant recipients in the 6 months following SARS-CoV-2 infection.
    Kidney Int. 2021;99:486-488.
    PubMed    


  68. RANKIN AJ, Mark PB
    Cardiac screening prior to renal transplantation-good intentions, rather than good evidence, dictate practice.
    Kidney Int. 2021;99:306-308.
    PubMed     Abstract available


    January 2021
  69. CHAVAROT N, Burger C, Aguilar C, Scemla A, et al
    Ig-responsive relapsing inflammatory syndrome following COVID-19 in a kidney transplant recipient.
    Kidney Int. 2021 Jan 22. pii: S0085-2538(20)31552.
    PubMed    


  70. THAUNAT O, Legeai C, Bastien O, Caillard S, et al
    Response to "On the need to better protect hemodialysis patients. A comment on the IMPORTANT study": one more IMPORTANT thing!
    Kidney Int. 2021 Jan 10. pii: S0085-2538(20)31527.
    PubMed    


  71. MASSIMO T, Hafedh F, Barbara PG
    On the need to better protect hemodialysis patients. A comment on "IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)".
    Kidney Int. 2021 Jan 9. pii: S0085-2538(20)31525.
    PubMed    


  72. VINSON AJ, Chong AS, Clegg D, Falk C, et al
    SEX MATTERS - COVID-19 IN KIDNEY TRANSPLANTATION.
    Kidney Int. 2021 Jan 4. pii: S0085-2538(20)31545.
    PubMed    


  73. DINH A, McCulloch CE, Ku E
    Predicting long-term kidney allograft outcomes: pitfalls and progress.
    Kidney Int. 2021;99:24-26.
    PubMed     Abstract available


    December 2020
  74. MURAKAMI N, Mulvaney P, Danesh M, Abudayyeh A, et al
    A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.
    Kidney Int. 2020 Dec 23. pii: S0085-2538(20)31534.
    PubMed     Abstract available


  75. STEL VS, de Jong RW, Kramer A, Andrusev AM, et al
    Supplemented ERA-EDTA Registry data evaluated the frequency of dialysis, kidney transplantation and comprehensive conservative management for patients with kidney failure in Europe.
    Kidney Int. 2020 Dec 21. pii: S0085-2538(20)31529.
    PubMed     Abstract available


  76. MALYSZKO J, Bamias A, Danesh FR, Debska-Slizien A, et al
    KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation.
    Kidney Int. 2020;98:1407-1418.
    PubMed     Abstract available


  77. CLARK EG, Knoll G
    More than ever, efficient evaluation of potential living kidney donors is needed.
    Kidney Int. 2020;98:1395-1397.
    PubMed     Abstract available


  78. SOFTELAND JM, Karason K, Magnusson J, Schult A, et al
    Registry reports in COVID-19 patients: juggling with big data, poor data, and no data.
    Kidney Int. 2020;98:1618.
    PubMed    


  79. HAZZAN M, Caillard S
    The authors reply.
    Kidney Int. 2020;98:1618-1619.
    PubMed    


    November 2020
  80. NIMMO A, Forsyth J, Oniscu G, Robb M, et al
    A propensity score matched analysis indicates screening for asymptomatic coronary artery disease does not predict cardiac events in kidney transplant recipients.
    Kidney Int. 2020 Nov 7. pii: S0085-2538(20)31258.
    PubMed     Abstract available


  81. BLOSSER CD, Haber G, Engels EA
    Changes in cancer incidence and outcomes among kidney transplant recipients in the United States over a thirty-year period.
    Kidney Int. 2020 Nov 4. pii: S0085-2538(20)31257.
    PubMed     Abstract available


  82. TURNER MP, Storey BC, Mittal S, Macanovic J, et al
    Candida crescents in a renal allograft.
    Kidney Int. 2020;98:1356.
    PubMed    


    October 2020
  83. THAUNAT O, Legeai C, Anglicheau D, Couzi L, et al
    IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT).
    Kidney Int. 2020 Oct 30. pii: S0085-2538(20)31206.
    PubMed     Abstract available


  84. DUJARDIN A, Chesneau M, Dubois F, Danger R, et al
    Clinical and immunological follow-up of very long-term kidney transplant recipients treated with calcineurin inhibitors indicates dual phenotypes.
    Kidney Int. 2020 Oct 30. pii: S0085-2538(20)31247.
    PubMed     Abstract available


  85. COATES PT
    A Kidney International "Journal of the COVID-19 Year" in Kidney Transplantation.
    Kidney Int. 2020 Oct 19. pii: S0085-2538(20)31204.
    PubMed    


  86. AZZI Y, Parides M, Alani O, Loarte-Campos P, et al
    COVID-19 infection in kidney transplant recipients at the epicenter of pandemics.
    Kidney Int. 2020 Oct 15. pii: S0085-2538(20)31202.
    PubMed     Abstract available


  87. GADE AR, Alavala H, Allam SR
    Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19.
    Kidney Int. 2020;98:1054.
    PubMed    


    September 2020
  88. JAGER KJ, Kramer A, Chesnaye NC, Couchoud C, et al
    Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe.
    Kidney Int. 2020 Sep 23. pii: S0085-2538(20)31081.
    PubMed     Abstract available


  89. SINGH N, Tandukar S, Zibari G, Naseer MS, et al
    Successful Simultaneous Pancreas and Kidney Transplant in a Patient Post-COVID-19 Infection.
    Kidney Int. 2020 Sep 15. pii: S0085-2538(20)31079.
    PubMed    


  90. BERCHTOLD L, Letouze E, Alexander MP, Canaud G, et al
    HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients.
    Kidney Int. 2020 Sep 1. pii: S0085-2538(20)30967.
    PubMed     Abstract available


    August 2020
  91. CAILLARD S, Anglicheau D, Matignon M, Durrbach A, et al
    An initial report from the French SOT COVID Registry suggests high mortality due to Covid-19 in recipients of kidney transplants.
    Kidney Int. 2020 Aug 24. pii: S0085-2538(20)30961.
    PubMed     Abstract available


  92. KNOLL GA, Fortin MC, Gill J, Grimshaw JM, et al
    Measuring Quality in Living Donation and Kidney Transplantation: Moving Beyond Survival Metrics.
    Kidney Int. 2020 Aug 10. pii: S0085-2538(20)30906.
    PubMed    


  93. RAYNAUD M, Aubert O, Reese PP, Bouatou Y, et al
    Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation.
    Kidney Int. 2020 Aug 8. pii: S0085-2538(20)30937.
    PubMed     Abstract available


  94. BONTHUIS M, Cuperus L, Chesnaye NC, Akman S, et al
    Results in the ESPN/ERA-EDTA Registry suggest disparities in access to kidney transplantation but little variation in graft survival of children across Europe.
    Kidney Int. 2020;98:464-475.
    PubMed     Abstract available


  95. NANKIVELL BJ
    The meaning of borderline rejection in kidney transplantation.
    Kidney Int. 2020;98:278-280.
    PubMed     Abstract available


  96. COATES PT, Wong G
    The forgotten fallen: painful reality of a pandemic.
    Kidney Int. 2020;98:251-252.
    PubMed    


  97. AZIZ F, Muth B, Parajuli S, Garg N, et al
    Unusually high rates of acute rejection during the COVID-19 pandemic: cause for concern?
    Kidney Int. 2020;98:513-514.
    PubMed    


  98. CHERUKURI A, Mehta R, Sharma A, Sood P, et al
    The authors reply.
    Kidney Int. 2020;98:516.
    PubMed    


  99. YIN S
    Post-transplant donor-specific antibody and outcomes with T cell-mediated rejection and nonadherence.
    Kidney Int. 2020;98:515-516.
    PubMed    


    July 2020
  100. HEYBELI C, Bentall A, Wen J, Alexander MP, et al
    A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis.
    Kidney Int. 2020 Jul 23. pii: S0085-2538(20)30830.
    PubMed     Abstract available


  101. KIM J, Perkins GB, Coates PT
    Evolutionary immunology: how your ancestry can affect your kidney transplant.
    Kidney Int. 2020;98:45-47.
    PubMed    


    June 2020
  102. LEE J, Huh KH
    Kidney transplantation trends in South Korea during the COVID-19 pandemic.
    Kidney Int. 2020 Jun 19. pii: S0085-2538(20)30692.
    PubMed    


  103. FERNANDEZ-RUIZ M, Seron D, Alonso A, Lora D, et al
    Derivation and external validation of the SIMPLICITY Score as a simple immune-based risk score to predict infection in kidney transplant recipients.
    Kidney Int. 2020 Jun 12. pii: S0085-2538(20)30638.
    PubMed     Abstract available


  104. GAUTIER-VARGAS G, Baldacini C, Benotmane I, Keller N, et al
    Rapid resolution of cytokine release syndrome and favorable clinical course of severe COVID-19 in a kidney transplant recipient treated with tocilizumab.
    Kidney Int. 2020 Jun 4. pii: S0085-2538(20)30622.
    PubMed    


  105. KEMMNER S, Guba M, Schonermarck U, Stangl M, et al
    Cyclosporine as preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.
    Kidney Int. 2020 Jun 4. pii: S0085-2538(20)30628.
    PubMed    


  106. ELENBERG E, O'Mahony CA, Eldin KW
    Ruptured gallbladder in cystinosis renal transplant recipient.
    Kidney Int. 2020;97:1304.
    PubMed    


  107. GOMEZ-ALDANA A, Tapias M, Rosselli D
    Opt-out in kidney transplantation rates: the Colombian experience.
    Kidney Int. 2020;97:1299.
    PubMed    


    May 2020
  108. ZHANG Z, Menon MC, Zhang W, Stahl E, et al
    Genome-wide non-HLA donor-recipient genetic differences influence renal allograft survival via early allograft fibrosis.
    Kidney Int. 2020 May 23. pii: S0085-2538(20)30540.
    PubMed     Abstract available


    April 2020
  109. MEHTA RB, Tandukar S, Jorgensen D, Randhawa P, et al
    Early subclinical tubulitis and interstitial inflammation in kidney transplantation have adverse clinical implications.
    Kidney Int. 2020 Apr 25. pii: S0085-2538(20)30408.
    PubMed     Abstract available


  110. SHIM YJ, Khedraki R, Dhar J, Fan R, et al
    Early T cell infiltration is modulated by programed cell death-1 protein and its ligand (PD-1/PD-L1) interactions in murine kidney transplants.
    Kidney Int. 2020 Apr 25. pii: S0085-2538(20)30430.
    PubMed     Abstract available


  111. BANERJEE D, Popoola J, Shah S, Ster IC, et al
    COVID-19 infection in kidney transplant recipients.
    Kidney Int. 2020 Apr 9. pii: S0085-2538(20)30361.
    PubMed     Abstract available


  112. COATES PT, Wong G, Drueke T, Rovin B, et al
    Early experience with COVID-19 in kidney transplantation.
    Kidney Int. 2020 Apr 9. pii: S0085-2538(20)30362.
    PubMed    


  113. ALBERICI F, Delbarba E, Manenti C, Econimo L, et al
    A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia.
    Kidney Int. 2020 Apr 9. pii: S0085-2538(20)30365.
    PubMed     Abstract available


  114. HEIDT S, Claas FHJ
    Not all HLA epitope mismatches are equal.
    Kidney Int. 2020;97:653-655.
    PubMed     Abstract available


    February 2020
  115. DE KOK MJ, Schaapherder AF, Mensink JW, de Vries AP, et al
    A nationwide evaluation of deceased donor kidney transplantation indicates detrimental consequences of early graft loss.
    Kidney Int. 2020 Feb 29. pii: S0085-2538(20)30224.
    PubMed     Abstract available


  116. DANGI A, Yu S, Lee FT, Burnette M, et al
    Murine cytomegalovirus dissemination but not reactivation in donor-positive/recipient-negative allogeneic kidney transplantation can be effectively prevented by transplant immune tolerance.
    Kidney Int. 2020 Feb 21. pii: S0085-2538(20)30151.
    PubMed     Abstract available


    January 2020
  117. SIGOGNE M, Culty T, Meria P, Demiselle J, et al
    Encrusted pyelitis in a kidney allograft.
    Kidney Int. 2020;97:217.
    PubMed    


  118. PERAZELLA MA, Shirali AC
    Immune checkpoint inhibitor nephrotoxicity: what do we know and what should we do?
    Kidney Int. 2020;97:62-74.
    PubMed     Abstract available


    November 2019
  119. SCHMIDT-LAUBER C, Buttner-Herold M, Schiffer M, Wiesener MS, et al
    Tuberculous granulomatous interstitial nephritis in a renal allograft.
    Kidney Int. 2019;96:1243.
    PubMed    


    October 2019
  120. SEKAR P, West BL, Henriksen KJ, Chang A, et al
    An incidental but pathognomonic finding in renal allograft biopsy.
    Kidney Int. 2019;96:1042.
    PubMed    


    May 2019
  121. LEE LOY J, Koratala A, De Los Santos Y, Chamarthi G, et al
    Disseminated toxoplasmosis: a life-threatening complication of inadequate posttransplant prophylaxis.
    Kidney Int. 2019;95:1274.
    PubMed    


    April 2019
  122. HOUSE AA, Wanner C, Sarnak MJ, Pina IL, et al
    Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Kidney Int. 2019 Apr 30. pii: S0085-2538(19)30276.
    PubMed     Abstract available


  123. NASR SH, Fogo AB
    New developments in the diagnosis of fibrillary glomerulonephritis.
    Kidney Int. 2019 Apr 9. pii: S0085-2538(19)30407.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Kidney Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: